Astera Labs (NASDAQ:ALAB) Stock Price Up 10.7% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price rose 10.7% during trading on Monday . The company traded as high as $451.07 and last traded at $449.8450. 844,785 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 5,677,063 shares. The stock had previously closed at $406.42.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ALAB. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Morgan Stanley raised their price target on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. UBS Group lifted their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research note on Monday, June 29th. Needham & Company LLC upped their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Evercore reissued an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $265.75.

Astera Labs Trading Up 8.2%

The stock has a market capitalization of $75.40 billion, a price-to-earnings ratio of 297.56, a price-to-earnings-growth ratio of 4.66 and a beta of 3.66. The company has a fifty day moving average of $314.72 and a two-hundred day moving average of $205.99.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter last year, the company posted $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, Director Bethany Mayer sold 686 shares of Astera Labs stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total value of $270,997.44. Following the transaction, the director owned 5,550 shares in the company, valued at $2,192,472. This trade represents a 11.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,981,441 shares of company stock worth $444,969,514 in the last quarter. 10.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Glenmede Trust Co. NA lifted its position in shares of Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the last quarter. Lido Advisors LLC increased its position in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after buying an additional 57 shares during the period. Perigon Wealth Management LLC increased its position in Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after buying an additional 73 shares during the period. Sound Income Strategies LLC lifted its holdings in shares of Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its position in shares of Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after acquiring an additional 84 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.